Researchers from the University of York in the UK analyzed the official drug sales figures received from the National Health Service of Italy between 2016-2018.
The study found that with the release of sales of CBD products, also known as Cannabis Lite because they contain very little THC, the psychoactive component, there was a sharp drop in sales of drugs for sleep and relaxation.
"With the sale of Cannabis Lite in a district, there was an average reduction of 12.3 in antidepressant sales, a decrease of 11.5 in sleep medications, and a decrease of 4.3 in antipsychotics," the study concludes.
In the year 2016, the Italian government approved a law aimed at facilitating the growth of industrial cannabis (HPP), in the framework of which some of the restrictions on the use of plant and its components were removed.
The purpose of the original law was to provide an incentive for other farmers to grow the cannabis (containing less than 0.2% THC without restriction on CBD), but deliberately or not the new law also created a legal loophole that allows for the sale of HMP inflorescences.
The consumption of Cannabis Lite and the Hap and CBD blooms are still prohibited by dry law and are sold as a "collectible" which is supposedly not intended for smoking, but the possession of the produce is not a crime.
The Cannabis Lite industry in Italy reached a value of about 6.5 million in 2018, and more than 300 new stores opened only last year - an increase of 75% over the previous year.
Cannabis Lite sales did not start all over Italy, so they examined each of the 106 districts in the country and checked what happened to the drug sales after the first cannabis lite stores were opened.
The Italians' interest in cannabis light as a substitute for anti-anxiety drugs is also reflected in Google's search data in Italy, which shows a dramatic increase in searches for Cannabis Lite and Cannabis Lite against anxiety after the start of sales.
"The results suggest that even moderate access to cannabis has a significant effect on the pharmaceutical market," the researchers concluded, and called on regulators to consider their attitude to the cannabis-lite market, taking into account the medical uses of CBD.
However, they also noted that the current situation in which Cannabis Lite is sold without any regulation or regulation is not ideal, and that its sale should be regulated like other drugs.
The biggest enemy of the cannabis light industry in Italy at present is Interior Minister Matteo Salvini, who He announced Announced that it intends to cancel the installation of 2016, which allowed the sale of THC-free cannabis with high CBD levels, among other reasons for fear that the stores sold "real" cannabis under the guise of "light".
Not only in Italy, the use of cannabis CBD has become a hit. In 75% of European countries It is permissible to use the same Cannabis Lite and some of them It is sold in kiosks At the corner of the street like a bloom or rolled cigarettes that have recently become for many a substitute for tobacco cigarettes.